04/24/2024 3:05 PM | Sarepta Therapeutics (Filer)
| Form DEF 14A | |
03/11/2024 7:00 PM | Estepan Ian Michael (Reporting) Sarepta Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/11/2024 7:00 PM | Brown Ryan Edward (Reporting) Sarepta Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/11/2024 7:00 PM | Boor Kathryn Jean (Reporting) Sarepta Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/11/2024 7:00 PM | Rodino-Klapac Louise (Reporting) Sarepta Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/11/2024 7:00 PM | Arif Bilal (Reporting) Sarepta Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/11/2024 7:02 PM | Sarepta Therapeutics (Issuer) Wigzell Hans Lennart Rudolf (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
|
03/11/2024 6:03 PM | Boor Kathryn Jean (Reporting) Sarepta Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/08/2024 4:38 PM | Sarepta Therapeutics (Subject) Wigzell Hans Lennart Rudolf (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/06/2024 7:00 PM | Rodino-Klapac Louise (Reporting) Sarepta Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/06/2024 7:00 PM | Arif Bilal (Reporting) Sarepta Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/06/2024 7:00 PM | Brown Ryan Edward (Reporting) Sarepta Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/06/2024 7:00 PM | Mayo Stephen (Reporting) Sarepta Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/06/2024 7:00 PM | Estepan Ian Michael (Reporting) Sarepta Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/05/2024 7:00 PM | Rodino-Klapac Louise (Reporting) Sarepta Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/05/2024 7:00 PM | Brown Ryan Edward (Reporting) Sarepta Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/05/2024 7:00 PM | Barry Richard (Reporting) Sarepta Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/05/2024 7:00 PM | Estepan Ian Michael (Reporting) Sarepta Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/05/2024 7:00 PM | Boor Kathryn Jean (Reporting) Sarepta Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/05/2024 7:00 PM | BEHRENS M KATHLEEN (Reporting) Sarepta Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/05/2024 7:00 PM | Chambers Michael Andrew (Reporting) Sarepta Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/05/2024 7:00 PM | Arif Bilal (Reporting) Sarepta Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/05/2024 7:00 PM | Sarepta Therapeutics (Issuer) Wigzell Hans Lennart Rudolf (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/05/2024 7:00 PM | Mayo Stephen (Reporting) Sarepta Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/05/2024 7:00 PM | Nicaise Claude (Reporting) Sarepta Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/05/2024 4:34 PM | Mayo Stephen (Reporting) Sarepta Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/01/2024 6:55 PM | Brown Ryan Edward (Reporting) Sarepta Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/01/2024 6:42 PM | Estepan Ian Michael (Reporting) Sarepta Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/01/2024 3:47 PM | Arif Bilal (Reporting) Sarepta Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/13/2024 12:34 PM | JANUS HENDERSON GROUP PLC (Filed by) Sarepta Therapeutics (Subject)
| Form SC 13G/A | |
01/26/2024 4:26 PM | BlackRock Inc. (Filed by) Sarepta Therapeutics (Subject)
| Form SC 13G/A | |
01/08/2024 11:08 AM | Sarepta Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/05/2023 7:00 PM | Arif Bilal (Reporting) Sarepta Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/20/2023 7:00 PM | Rodino-Klapac Louise (Reporting) Sarepta Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/06/2023 7:00 AM | BEHRENS M KATHLEEN (Reporting) Sarepta Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/06/2023 7:00 AM | INGRAM DOUGLAS S (Reporting) Sarepta Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/06/2023 7:00 AM | Barry Richard (Reporting) Sarepta Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/15/2023 7:00 AM | Chambers Michael Andrew (Reporting) Sarepta Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/14/2023 7:00 AM | Chambers Michael Andrew (Reporting) Sarepta Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/11/2023 6:40 AM | Chambers Michael Andrew (Reporting) Sarepta Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/08/2023 7:00 PM | Sarepta Therapeutics (Issuer) Wigzell Hans Lennart Rudolf (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
Protect Yourself While There’s Still Time … (Ad) The next step of the Fed's control is here.
Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week.
Allowing the Fed to tighten its grip on your personal privacy and freedom. 4 simple steps to protect your privacy and money before it’s too late. |
08/04/2023 5:25 PM | Sarepta Therapeutics (Subject) Wigzell Hans Lennart Rudolf (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/02/2023 3:02 PM | Sarepta Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
06/22/2023 3:49 PM | Sarepta Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/22/2023 1:22 PM | Sarepta Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/05/2023 7:00 PM | Brown Ryan Edward (Reporting) Sarepta Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |